Добірка наукової літератури з теми "Adjuvant-free"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Adjuvant-free".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Adjuvant-free"
Conrad, M. L., A. Ö. Yildirim, S. S. Sonar, A. Kılıç, S. Sudowe, M. Lunow, R. Teich, H. Renz, and H. Garn. "Comparison of adjuvant and adjuvant-free murine experimental asthma models." Clinical & Experimental Allergy 39, no. 8 (August 2009): 1246–54. http://dx.doi.org/10.1111/j.1365-2222.2009.03260.x.
Повний текст джерелаHutchinson, Lisa. "Paclitaxel adjuvant therapy improves relapse-free survival." Nature Reviews Clinical Oncology 6, no. 8 (August 2009): 437. http://dx.doi.org/10.1038/nrclinonc.2009.100.
Повний текст джерелаJones, Rachel S. "Adjuvant imatinib mesylate therapy improves recurrence-free survival." Nature Reviews Gastroenterology & Hepatology 6, no. 6 (June 2009): 320. http://dx.doi.org/10.1038/nrgastro.2009.80.
Повний текст джерелаJin, Yining, Haoran Gao, Rick Jorgensen, Jillian Salloum, Dan Ioan Jian, Perry K. W. Ng, and Venugopal Gangur. "Mechanisms of Wheat Allergenicity in Mice: Comparison of Adjuvant-Free vs. Alum-Adjuvant Models." International Journal of Molecular Sciences 21, no. 9 (May 1, 2020): 3205. http://dx.doi.org/10.3390/ijms21093205.
Повний текст джерелаFelip, Enriqueta, Rafael Rosell, José Antonio Maestre, José Manuel Rodríguez-Paniagua, Teresa Morán, Julio Astudillo, Guillermo Alonso, et al. "Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer." Journal of Clinical Oncology 28, no. 19 (July 1, 2010): 3138–45. http://dx.doi.org/10.1200/jco.2009.27.6204.
Повний текст джерелаEilber, F., A. Giuliano, J. Eckardt, K. Patterson, S. Moseley, and J. Goodnight. "Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial." Journal of Clinical Oncology 5, no. 1 (January 1987): 21–26. http://dx.doi.org/10.1200/jco.1987.5.1.21.
Повний текст джерелаLogothetis, C. J., D. E. Johnson, C. Chong, F. H. Dexeus, A. Sella, S. Ogden, T. Smith, D. A. Swanson, R. J. Babaian, and K. I. Wishnow. "Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update." Journal of Clinical Oncology 6, no. 10 (October 1988): 1590–96. http://dx.doi.org/10.1200/jco.1988.6.10.1590.
Повний текст джерелаMeyers, Brandon Matthew, Humaid Obaid Al-Shamsi, and Alvaro Tell Figueredo. "Cochrane systematic review and meta-analysis of adjuvant chemotherapy for stage II colon cancer." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 3548. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.3548.
Повний текст джерелаLi, Meichen, Xue Hou, Suxia Lin, Lie Zheng, Jianzhong Liang, Jing Chen, Na Wang, Baishen Zhang, and Likun Chen. "Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated non-small-cell lung cancer: a meta-analysis." Future Oncology 18, no. 9 (March 2022): 1159–69. http://dx.doi.org/10.2217/fon-2021-0934.
Повний текст джерелаSakin, Abdullah, Nurgul Yasar, Suleyman Sahin, Serdar Arici, Saban Secmeler, Orcun Can, Caglayan Geredeli, Cumhur Demir, and Sener Cihan. "Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study." Journal of Oncology Pharmacy Practice 26, no. 3 (August 1, 2019): 619–31. http://dx.doi.org/10.1177/1078155219865008.
Повний текст джерелаДисертації з теми "Adjuvant-free"
Chen, Cha-May, and 陳加美. "Designing adjuvant-free vaccine: GnRH vaccine as an example." Thesis, 2011. http://ndltd.ncl.edu.tw/handle/78085824908963614784.
Повний текст джерела國立陽明大學
生化暨分子生物研究所
99
Adjuvant and epitope containing antigen from particular protein of pathogen or self antigens to induced immune response are the two major components of vaccine. Since the epitope alone, a small peptide, usually has poor immunogenicity, adjuvant is needed to enhance the immune response. However, the use of adjuvant always raises unexpected adverse side effects. Thus, the safety issue of using adjuvant is still a major concern in vaccine development. In this study, we develop an adjuvant-free peptide vaccine which comprises with linear epitopes with a carrier protein for delivery to specifically enhance the immunogenicity of the antigen without adding adjuvant. We use GnRH (Gonadotropin-releasing hormone) as our antigen not only because a self antigen with low immunogenicity but also a key hormone that regulate the maturation of sex organ. We designed the immunogen as the Pseudomonas exotoxin receptor–binding domain and 12 copies of GnRH (PE1a-GnRH12) in linear array and immunized with female BALB/C mice 10μg and 20μg respectively. Compare with the adjuvanted GnRH peptide vaccine, after immunization, the adjuvant-free GnRH peptide vaccine resulted in lower Anti-GnRH antibody titer, however, the adjuvant-free GnRH peptide vaccine still manifest reduced the ability of reproduction and degenerated the folliculogenesis in immunized mice. The result indicate, instead using adjuvant, the adjuvant-free GnRH peptide vaccine can be a potential therapeutic application with a safer property. Since the linear polypeptide vaccine may have the risk to generate antibody to junction epitope which can suppress the function of the vaccine or cause undesired immune response, we improve the fusion protein by designing a carrier protein conjugated with GnRH peptides in different ratio to prevent the production of junction epitope in the immunogen. Among different ratio of the carrier protein-GnRH peptide conjugates(referred to GnRH vaccine), the higher ratio of the GnRH vaccine have more GnRH peptide conjugates analyzed by MALDI-TOF. In animal study, the higher GnRH containing vaccine have higher anti-GnRH antibody titer and influence the estrus cycle of the immunized BALB/C mice. The results indicate the GnRH vaccine can be a potential application not only prevent the production of junction epitope but also a platform for different vaccine design.
Zhang, Bingyang. "Hepatitis B core (HBc) virus like particle (VLP) as a platform for innovation of chimeric adjuvant-free VLP vaccines targeting oncoviruses." Thesis, 2021. http://hdl.handle.net/2440/130894.
Повний текст джерелаThesis (Ph.D.) -- University of Adelaide, School of Chemical Engineering and Advanced Materials, 2021
Книги з теми "Adjuvant-free"
McLeon, Kelly. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer. Edited by SreyRam Kuy and Miguel A. Burch. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199384075.003.0011.
Повний текст джерелаKulkarni, Kunal, James Harrison, Mohamed Baguneid, and Bernard Prendergast, eds. Gastrointestinal and hepatobiliary surgery. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198729426.003.0023.
Повний текст джерелаEisen, Tim. The patient with renal cell cancer. Edited by Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0172.
Повний текст джерелаЧастини книг з теми "Adjuvant-free"
Domenge, C., J. L. Marin, J. P. Droz, F. Eschwege, G. Schwaab, and J. M. Richard. "Post-Radiotherapy Adjuvant Chemotherapy of Regionally Advanced UNPC: Increase in Disease Free Survival." In Epstein-Barr Virus and Human Disease, 491–95. Totowa, NJ: Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4590-2_105.
Повний текст джерелаHwang, Eugene I., and Roger J. Packer. "Event-Free Survival of Children with Average-Risk Medulloblastoma: Treatment with Craniospinal Radiation Followed by Adjuvant Chemotherapy." In Pediatric Cancer, Volume 4, 93–101. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6591-7_10.
Повний текст джерелаDahm, Philipp. "Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer." In 50 Studies Every Urologist Should Know, 61–66. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190655341.003.0011.
Повний текст джерелаMadhavan Nair, Lekha, Rejnish Ravi Kumar, Malu Rafi, Farida Nazeer, Kainickal Cessal Thommachan, and Kunnambath Ramadas. "Chemotherapy in Nasopharyngeal Carcinoma." In Pharynx - Diagnosis and Treatment. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.98550.
Повний текст джерелаSNIDER, DENIS P. "ADJUVANT-FREE POLYCLONAL ANTIBODY RESPONSE MANIPULATED BY ANTIBODY-MEDIATED ANTIGEN TARGETING." In Antibody Techniques, 49–69. Elsevier, 1994. http://dx.doi.org/10.1016/b978-0-12-466460-9.50006-7.
Повний текст джерелаMcCarville, Justin L., Alberto Caminero, and Elena F. Verdu. "Celiac Treatments, Adjuvant Therapies and Alternatives to the Gluten-Free Diet." In Advances in the Understanding of Gluten related Pathology and the Evolution of Gluten-Free Foods, 223–53. OmniaScience, 2015. http://dx.doi.org/10.3926/oms.254.
Повний текст джерелаSheri, Amna, and Laura Morrison. "Endocrine Treatment of Breast Cancer." In Oxford Textbook of Endocrinology and Diabetes 3e, edited by John A. H. Wass, Wiebke Arlt, and Robert K. Semple, 1782–89. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198870197.003.0220.
Повний текст джерелаEvans, Gregory R. D. "Introduction." In Operative Plastic Surgery, edited by Gregory R. D. Evans, 3–6. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780190499075.003.0001.
Повний текст джерелаMuraleedharan, Amitha, Sagar Kumar, and Rashmi Mittal. "Pre-Clinical and Clinical Evidence of Recent Therapeutic Trends and Spotting Possibility of Cure in Near Future." In Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer, 73–98. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815079784123010007.
Повний текст джерелаAlmefty, Rami O., and Ossama Al-Mefty. "Chordomas and chondrosarcomas of the skull base." In Oxford Textbook of Neurological Surgery, edited by Ramez W. Kirollos, Adel Helmy, Simon Thomson, and Peter J. A. Hutchinson, 189–96. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198746706.003.0015.
Повний текст джерелаТези доповідей конференцій з теми "Adjuvant-free"
Conrad, ML, AO Yildirim, SS Sonar, A. Kilic, S. Sudowe, M. Lunow, R. Teich, H. Renz, and H. Garn. "The Benefits of the Adjuvant-Free Murine Experimental Asthma Model. Adjuvant and Adjuvant-Free Protocols Produce Similar Phenotypes." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4223.
Повний текст джерелаFranzen, A., M. Färber, S. Strieth, and D. Dietrich. "Cell-free circulating DNA-methylation as biomarker for monitoring adjuvant and palliative immunotherapies." In 100 JAHRE DGHNO-KHC: WO KOMMEN WIR HER? WO STEHEN WIR? WO GEHEN WIR HIN? Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1727964.
Повний текст джерелаJain, Vandana, Rupinder Sekhon, Shveta Giri, and Sudhir Rawal. "Role of radical surgery in early stages of vaginal cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685350.
Повний текст джерелаGarcía-González, X., M. Pellicer, MI García, P. García-Alfonso, C. Grávalos, V. Pachón, V. Martinez, P. Martinez-Ortega, M. Sanjurjo, and LA López-Fernández. "PKP-007 Dpyd snps and disease free survival after capecitabine based adjuvant treatment in colorectal cancer." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.435.
Повний текст джерелаPitman, NI, GE Murphy, P. Kewin, D. Xu, C. McSharry, NC Thomson, and MC Shepherd. "ST2 Gene-Deletion Attenuates Airways Inflammation and IgE Production in an Adjuvant-Free Model of Asthma." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2248.
Повний текст джерелаDale, Nicole, Kristof Raemdonck, Anthony T. Nials, Maria G. Belvisi, and Mark A. Birrell. "Inflammation And Airway Responsiveness In A House Dust Mite-Driven, Adjuvant-Free Model Of Allergic Asthma." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2837.
Повний текст джерелаMorante, Z., G. De la Cruz-Ku, J. Pinto, J. Araujo, H. Fuentes, D. Enriquez, R. Luque, et al. "Abstract P1-15-02: Benefit of adjuvant chemotherapy in disease-free survival for T1N0 triple negative breast cancer." In Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.sabcs17-p1-15-02.
Повний текст джерелаNakamori, S., N. Miyajima, S. Hyuga, Y. Minami, H. Kazama, M. Hiyama, M. Endo, et al. "Therapeutic and analgesic effects of ephedrine alkaloids-free Ephedra Herb extract on complete Freud’s adjuvant-induced arthritis model mouse." In 67th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) in cooperation with the French Society of Pharmacognosy AFERP. © Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-3399686.
Повний текст джерелаHuang, Yu-Hsiang, Pei-Yi Chu, Ji-Lin Chen, Chun-Teng Huang, Chia-Han Lee, Ka-Yi Lau, Wan-Lun Wang, et al. "Abstract 4612: SET overexpression is associated with recurrence-free survival in patients with primary breast cancer receiving adjuvant tamoxifen treatment." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-4612.
Повний текст джерелаReinisch, M., J. O’Shaughnessy, P. Rastogi, S. Johnston, M. Martin, N. Harbeck, M. Toi, et al. "Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib plus adjuvant endocrine therapy for high-risk early breast cancer." In Wissenschaftliche Abstracts zur 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V. (DGS) Interdisziplinär. Kommunikativ. Digital. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1730206.
Повний текст джерела